close
MENU
Hot Topic EARNINGS
Hot Topic EARNINGS
NBR View

EpiPen, Spinraza funding leaves bitter-sweet heaviness

Read Article
Fri, 30 Sep 2022

Bad employers taken to task in new anti-migrant exploitation bill

Read Article
Thu, 29 Sep 2022

Dealmakers 2022: adviser focus - EY

Read Article
Thu, 29 Sep 2022

Chief Ombudsman ‘exercises moral authority’ to clean up OIAs

Read Article
Thu, 29 Sep 2022

Recession or not, New Zealand should back itself

Read Article
Thu, 29 Sep 2022

Russia-Ukraine war a salutary lesson for Māori economy

Read Article
Thu, 29 Sep 2022

How many central bankers should really lose their jobs?

Read Article
Thu, 29 Sep 2022

Shrink-wrap comes off Auckland’s renewed Chief Post Office

Read Article
Wed, 28 Sep 2022

Dealmakers 2022: adviser focus – Russell McVeagh

Read Article
Wed, 28 Sep 2022

Dealmakers 2022: why Bentley is so pleased with its Seequent buy

Read Article
Wed, 28 Sep 2022

Rattle your dags, National, and tell us your climate policy

Read Article
Wed, 28 Sep 2022

Moral panic on GE has abated

Read Article
Wed, 28 Sep 2022
1 209 210 211 212 213 564